the initial low dose vincristine , actinomycin , and cyclophosphamide ( ldvac ) regimen proved ineffective , actuarial survival at 5 years followup being 8 % ( 12 patients ) , and a regimen of cisplatin , vinblastine , and bleomycin ( pvb ) caused unacceptable toxicity , with actuarial survival at 5 years follow-up being 67 % ( nine patients ) .
C0042670
vinblastine
C0072634
pvb